hrp0095p2-198 | Growth and Syndromes | ESPE2022

Efficacity of Growth Hormone Treatment in Children with Intrauterine Growth Restriction IUGR

Baz Ouidad , Aboussamaane Souha , Benachour Soumia , Mimoun Sofia

WHO defines children born with intrauterine growth restriction (IUGR) as those with a birth weight below the 10th percentile of recommended birth weight by sex for gestational age. When gestational age is not available, a birth weight < 2500 g should be considered. The adult height in IUGR children treated with GH depends mainly on the duration of treatment and the age of initiation. Early diagnosis and early management before puberty are therefore imperative.<p class="...

hrp0095p2-86 | Diabetes and Insulin | ESPE2022

Type 1 diabetes in children: What are the particularities?

Ourdi Amal , Hajar Charif , Latifa Yagoubi , Najoua Messaoudi , Soumia Berrabeh , Siham Rouf , Hanane Latrech

Introduction: Children’s type 1 diabetes is a rare entity, its prevalence is still poorly known, which makes its diagnosis, therapeutic management and prognosis increasingly difficult and uncodified. The purpose of our study is to report the experience of the Endocrinology - Diabetology and Nutrition Department in the management of diabetes in children.Methods: This is a retrospective, descriptive study including 1...

hrp0086p1-p246 | Diabetes P1 | ESPE2016

Wolcott Rallison Syndrome due to a Novel Mutation in EIF2AK3 Gene

Bhaskar Vikram , Thunga Chennakeshava , Tiwari Soumya

Background: Wolcott Rallison syndrome is a rare autosomal recessive disorder, characterized by early onset diabetes, skeletal dysplasia and growth retardation. Fewer than 100 cases have been reported in literature. We report a case of Wolcott Rallison syndrome caused by a novel mutation.Objective and hypotheses: To report a novel mutation of EIF2AK3 gene, which has never been reported previously.Method: Blood sample of a suspected ...

hrp0086rfc3.2 | Pituitary | ESPE2016

Subfertility After Chemotherapy in PNET Tumours: 34 year Experience from a Single Centre (1980–2013)

Serra-Caetano Joana , Pandalai Soumya , Phipps Kim , Spoudeas Helen Alexandra

Background: PanEuropean(SIOP) trials of treatment for childhood brain cancers (medulloblastomas/PNET) showed a 5% survival advantage with ‘sandwich’ gonadotoxic chemotherapy (CT) over surgical excision, neuraxial radiation and tumour boost (RT) alone. But this was tempered by a reduced quality of survival at 7 years.Objective: To assess the long term prevalence of subfertility after CT with/without neuraxial radiation.<p class="a...

hrp0095p2-157 | GH and IGFs | ESPE2022

Prevalence of Childhood Short Stature and weight variations Among Primary School Children

Berrabeh Soumiya , Bouali Houda , Boujtat Khadija , Assarrar Imane , Rouf Siham , Latrech Hanane

Keywords: short stature, underweight, overweight, obesityIntroduction: Natural growth is an important indicator of health in childhood. Growth retardation can result from systemic and endocrine diseases or poor diet. Being overweight or obese in childhood increases the risk of morbidity and mortality in adulthood. This study, the first of its kind in Morocco, was conducted to compare the prevalence of growth disorders am...

hrp0095p2-209 | Multisystem Endocrine Disorders | ESPE2022

Fahr's syndrome in children: About 2 cases

Berrabeh Soumiya , Elmehraoui Ouafae , Messaoudi Najoua , Assarrar Imane , Rouf Siham , Latrech Hanane

Keywords: Basal ganglia calcifications, hypoparathyroidism, farh's diseaseIntroduction: Fahr syndrome is a rare anatomical-clinical entity, defined radiologically by the presence of bilateral, symmetrical, non-arteriosclerotic triatopallidodentate calcifications. Its diagnosis is radiological, and must be distinguished from Fahr's disease, which corresponds to the presence of calcifications without abnormalitie...